HIKMA Pharmaceuticals PLC

Director's Dealing • Jun 5, 2024

National Storage Mechanism | Additional information

RNS Number : 2745R

Hikma Pharmaceuticals Plc

05 June 2024

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Grant of a pledge by the Executive Chairman over 820,416 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of EFG Private Bank UK Limited.
c)	Price(s) and volume(s)	Price(s): £0.00p Volume(s): 820,416
d)	Aggregated information	Aggregated volume: 820,416 Price: £0.00p
e)	Date of the transaction	31 May 2024
f)	Place of the transaction	Outside a trading venue

Helen Middlemist

Group Company Secretary

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBXGDLDUGDGSU